BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18752499)

  • 1. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2.
    Houghton O; Connolly LE; McCluggage WG
    Histopathology; 2008 Aug; 53(2):156-65. PubMed ID: 18752499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia.
    Chiarelli S; Buriticá C; Litta P; Ciani S; Guarch R; Nogales FF
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4251-6. PubMed ID: 16857799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation.
    Wani Y; Notohara K; Saegusa M; Tsukayama C
    Hum Pathol; 2008 Jul; 39(7):1072-9. PubMed ID: 18495206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation of diffuse Cdx2 expression in endometrioid adenocarcinoma in the absence of morules.
    Wani Y
    Histopathology; 2009 Mar; 54(4):495-7. PubMed ID: 19309406
    [No Abstract]   [Full Text] [Related]  

  • 5. SATB2 is Consistently Expressed in Squamous Morules Associated With Endometrioid Proliferative Lesions and in the Stroma of Atypical Polypoid Adenomyoma.
    McCluggage WG; Van de Vijver K
    Int J Gynecol Pathol; 2019 Sep; 38(5):397-403. PubMed ID: 30085940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morules and morule-like features associated with carcinomas in various organs: report with immunohistochemical and molecular studies.
    Makishi S; Kinjo T; Sawada S; Chinen K; Hirayasu T; Hamada T; Saito K; Iwamasa T
    J Clin Pathol; 2006 Jan; 59(1):95-100. PubMed ID: 16394288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between morular metaplasia and squamous differentiation in endometrial carcinoma.
    Travaglino A; Raffone A; Gencarelli A; Raimondo D; Moretta P; Pignatiello S; Granata M; Seracchioli R; Zullo F; Insabato L
    Pathol Res Pract; 2021 Jan; 217():153307. PubMed ID: 33316539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation.
    Saegusa M; Okayasu I
    J Pathol; 2001 May; 194(1):59-67. PubMed ID: 11329142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant nuclear beta-catenin expression in the spindle or corded cells in so-called corded and hyalinized endometrioid carcinomas. Another critical role of the unique morphological feature.
    Wani Y; Saegusa M; Notohara K
    Histol Histopathol; 2009 Feb; 24(2):149-55. PubMed ID: 19085831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional role of Cdx2 in beta-catenin signaling during transdifferentiation in endometrial carcinomas.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Wani Y; Okayasu I
    Carcinogenesis; 2007 Sep; 28(9):1885-92. PubMed ID: 17468517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morules in endometrial carcinoma and benign endometrial lesions differ from squamous differentiation tissue and are not infected with human papillomavirus.
    Chinen K; Kamiyama K; Kinjo T; Arasaki A; Ihama Y; Hamada T; Iwamasa T
    J Clin Pathol; 2004 Sep; 57(9):918-26. PubMed ID: 15333650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.
    Wang L; Rambau PF; Kelemen LE; Anglesio MS; Leung S; Talhouk A; Köbel M
    Histopathology; 2019 Feb; 74(3):452-462. PubMed ID: 30326146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shadow cell differentiation from squamoid morule in endometrial adenoacanthoma.
    Nakamura T
    Int J Clin Exp Pathol; 2015; 8(10):13120-4. PubMed ID: 26722510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotin-rich, optically clear nuclei express estrogen receptor-beta: tumors with morules may develop under the influence of estrogen and aberrant beta-catenin expression.
    Nakatani Y; Masudo K; Nozawa A; Inayama Y; Yamanaka S; Ito T; Kitamura H; Notohara K; Kashima K; Yokoyama S; Tsujimoto M; Tamai S; Abe Y; Resl M; Mark EJ
    Hum Pathol; 2004 Jul; 35(7):869-74. PubMed ID: 15257551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers.
    Niu S; Lucas E; Molberg K; Strickland A; Wang Y; Carrick K; Rivera-Colon G; Gwin K; SoRelle JA; Castrillon DH; Zheng W; Chen H
    Am J Surg Pathol; 2022 Oct; 46(10):1447-1455. PubMed ID: 35834400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morules in cribriform-morular variant of papillary thyroid carcinoma: Immunohistochemical characteristics and distinction from squamous metaplasia.
    Hirokawa M; Kuma S; Miyauchi A; Qian ZR; Nakasono M; Sano T; Kakudo K
    APMIS; 2004; 112(4-5):275-82. PubMed ID: 15233643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
    Heckl M; Schmoeckel E; Hertlein L; Rottmann M; Jeschke U; Mayr D
    PLoS One; 2018; 13(2):e0192881. PubMed ID: 29451900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.